Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/viatris-hosts-rd-event-focusing-on-its-collaboration-with-idorsia-phase-3-assets-selatogrel-and-cenerimod-and-key-elements-of-its-pipeline-302100327.html
https://www.globenewswire.com/news-release/2024/03/18/2847447/0/en/Idorsia-and-Viatris-successfully-close-the-transaction-for-the-global-research-and-development-collaboration.html
https://www.biospace.com/article/fda-rejects-viatris-mapi-s-long-acting-multiple-sclerosis-injection/
https://www.prnewswire.com/news-releases/viatris-reports-fourth-quarter-and-full-year-2023-financial-results-and-provides-2024-financial-guidance-302073719.html
https://www.reuters.com/business/healthcare-pharmaceuticals/viatris-forecasts-strong-2024-sales-higher-demand-branded-drugs-2024-02-28/
https://www.globenewswire.com//news-release/2024/02/28/2836599/0/en/Idorsia-and-Viatris-enter-into-a-significant-global-research-and-development-collaboration.html
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=079074
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209986
https://www.prnewswire.com/news-releases/viatris-to-announce-fourth-quarter-and-full-year-2023-financial-results-302052745.html
https://www.bloomberg.com/news/articles/2023-12-27/regeneron-gains-after-eye-drug-patent-victory-over-viatris